Cannabis Strategic Ventures NUGS OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

23/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cannabis Strategic Ventures (NUGS) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 22/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

23/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

15/100

→ Income

✓

成长

90/100

→ Income

✗

收入

10/100

→ Income

估值概览 — NUGS

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.04

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.03

每股账面价值$0.00

每股营收$0.03

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2005	$-3.00	$11.18K	$-6.68M	-59771%
2013	$0.00	$372.11K	$49.21K	13.2%
2014	$0.00	$149.56K	$11.81K	7.9%
2015	$0.00	$0.00	$-73.78K	-
2016	$0.00	$0.00	$85.97K	-
2017	$0.00	$344.7K	$-8.41M	-2439.8%
2018	$-0.08	$701.97K	$-21.43M	-3053.3%
2019	$-0.04	$2.37M	$-9.06M	-382.6%
2020	$-0.02	$14.6M	$-5.64M	-38.6%
2021	$-0.03	$9.85M	$-8.6M	-87.3%